Adage Capital Partners Gp, L.L.C. Uro Gen Pharma Ltd. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,928,086 shares of URGN stock, worth $33.8 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,928,086
Previous 3,735,741
21.62%
Holding current value
$33.8 Million
Previous $47.4 Million
34.27%
% of portfolio
0.06%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding URGN
# of Institutions
137Shares Held
36.2MCall Options Held
57.7KPut Options Held
9.8K-
Rtw Investments, LP New York, NY3.83MShares$44.3 Million0.67% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$26.6 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$25.3 Million0.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A61.75MShares$20.2 Million0.03% of portfolio
-
Vestal Point Capital, LP New York, NY1.63MShares$18.8 Million1.03% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $263M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...